A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation
A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation
Recruiting · NCT06659341 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation | Advanced Solid Tumors Harboring KRAS G12C Mutation | Recruiting | Phase 1 | 2026-09-23 | NCT06659341 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Border Medical oncology - Albury Wodonga Regional Cancer Centre | Albury | Australia | 2 |
| Cabrini Health Oncology Research | Malvern | Australia | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Oncologia Medica | Roma | Italy | 3 |
| Hospital Universitari Vall D Hebron | Oncologia | Barcelona | Spain | 6 |
| Humanitas Mirasole S.p.A. - Oncologia Medica ed Ematologia | Rozzano | Italy | 5 |
| Institut Catala D'oncologia | Hospitalet | Oncologia | Barcelona | Spain | 1 |
| Macquarie University Hospital - Oncology Department | Macquarie Park | Australia | 1 |
| Peninsula and Southeast Oncology | Frankston | Australia | 3 |
| Rigshospitalet Copenhagen University Hospital | Oncology Department | Copenhagen | Denmark | 5 |
| The Christie Hospital | Oncology | Manchester | United Kingdom | 1 |
| The Royal Marsden (Surrey) | Oak Foundation Drug Development Unit | Sutton | United Kingdom | 2 |